Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies

Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies

US Patent 9617600 · Granted Apr 11, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-Dectin-2 antibodies and methods of using2025
Anti-Dectin-2 antibodies2023
Anti-CD79B antibodies and immunoconjugates and methods of use2021
Anti-CD79B antibodies and immunoconjugates and methods of use2020
Anti-CD79B antibodies and immunoconjugates and methods of use2019
Tank-binding kinase inhibitor compounds2019
Diagnostic markers for treating cell proliferative disorders with telomerase inh2018
Anti-CD79B antibodies and immunoconjugates and methods of use2018
Diagnostic markers for treating cell proliferative disorders with telomerase inh2015
Methods and compositions for assessing responsiveness of B-cell lymphoma to trea2015
Methods and compositions for assessing responsiveness of B-cell lymphoma to trea2015
Anti-CD79B antibodies and immunoconjugates and methods of use2014